NCT06816108View on ClinicalTrials.gov

A Study of ONO-7428 in Participants With Unresectable Advanced or Recurrent Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 21, 2025

Primary Completion Date

July 31, 2029

Study Completion Date

July 31, 2029

Conditions
Solid TumorNSCLC
Interventions
DRUG

ONO-7428

Specified dose on specified days

Trial Locations (3)

Unknown

RECRUITING

National Cancer Center Hospital East, Kashiwa-shi

RECRUITING

Osaka International Cancer Institute, Osaka

RECRUITING

The Cancer Institute Hospital Of JFCR, Koto-Ku

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY